Introduction

!
Screening colonoscopy is recognized as the gold standard modality for the prevention of colorectal cancer (CRC) [1, 2] . In 2013, seven European Union (EU) states used either screening colonoscopy alone or in combination with fecal occult blood testing as a primary screening tool [3] . As screening colonoscopy is an invasive procedure on a healthy screening population, the benefit must be as high as possible and the risks (e. g. bleeding, perforation) must be reduced to a minimum. In recent years, the quality of endoscopic equipment, bowel preparation, and skill of the individual endoscopist has improved considerably, and guidelines have required increasingly higher quality standards [4 -6] . The current EU guideline emphasizes that "infrequent high quality examinations are probably more effective in prevention of colorectal cancer than are frequent low quality examinations" [7] . The outstanding benefit of quality assurance programs with constant audit and feedback on both improving the procedure as well as setting new standards has been demonstrated in several landmark publications [8 -10] . However, in Europe such programs are scarce. Background and study aim: Screening colonoscopy only effectively prevents colorectal cancer if performed with high quality. The aim of this study was to analyze the detection rates of premalignant colorectal lesions in screening colonoscopies performed within a nationwide quality control program for screening colonoscopy in Austria. Methods: Data from electronic records of the screening program from its implementation in 2007 until December 2014 were analyzed in order to calculate detection rates for adenomas, advanced adenomas, polyps, and proximal lesions, and rates of cecal intubation, sedation, complications, and adequate bowel preparation. Results were evaluated to identify trends and changes in quality parameters over the 8-year study period. Results: During the study period, 301 endoscopists provided data from 159 246 screening colonoscopies. Mean age of screened individuals was 61.1 years, and 49.1 % were women. Significant increases over time were found for age-and sex-adjusted adenoma detection rates (ADRs), which increased from a mean of 22.2 % (SD 10. within the nationwide quality assurance program for screening colonoscopy in Austria.
Methods
!
Data from electronic records of the quality assurance program for screening colonoscopy, from its implementation in 2007 until December 2014, were analyzed in order to calculate detection rates for adenomas, advanced adenomas, polyps, and proximal lesions, and rates of cecal intubation, sedation, complications, and adequate bowel preparation. Results were evaluated to identify trends and changes in quality parameters over the 8-year study period. The study period was divided into four 2-year blocks and detection rates were computed within these blocks. Only those participants who had performed at least 20 colonoscopies during the study blocks were included in the study.
The screening program
In Austria, publicly funded opportunistic screening colonoscopy was implemented in 2005 as a primary CRC screening method for the average-risk population starting at the age of 50 years for both men and women. Because of the lack of obligatory quality assurance for screening colonoscopy, the Austrian Society of Gastroenterology and Hepatology in cooperation with the Austrian Federation of the Statutory Insurance Institutions and the Austrian Cancer Aid founded, in 2007, a national project for quality assurance in screening colonoscopy, the "Certificate of Quality for Screening Colonoscopy." Minimum quality requirements for participation in the screening program include proof of performing at least 200 supervised colonoscopies and 50 supervised polypectomies, as well as an ongoing rate of 100 colonoscopies and 10 polypectomies per year of participation, photographic documentation of the cecum in each screened individual, and annual hygiene checks of the endoscopic equipment [11 -17] . Every internist, gastroenterologist, or surgeon who meets these criteria, can apply for the certificate; nurses do not perform endoscopy in Austria. Participation in the quality assurance program is on a voluntary basis. The certificate of the quality assurance program is issued for a period of 2 years, after which it must be renewed in order for the operator to continue performing screening colonoscopies within the program. Data on patient characteristics (age, sex) and the following colonoscopy report details are transmitted electronically via a standardized report form to the database of the quality assurance program: number, size, location and histology of the lesion detected; polypectomy technique; complications; recommended surveillance interval. If more than one lesion is detected, details of the size, shape, histology, location, and polypectomy technique for the most advanced lesion only are documented. The electronic reporting form is adapted continually according to ongoing progress in scientific research, for example introduction of the terms "traditional" and "sessile serrated adenoma," assessment of bowel preparation (excellent, good, fair, poor, poor only in the rightsided colon, not sufficient; based on the Aronchick scale). Screening data can only be transmitted and used if the screened individuals have provided written informed consent for data transmission, and the use of their data for quality assurance and scientific purposes. The ethics committee of the Medical University of Vienna and the Data Protection commission approved the "Certificate of Quality for Screening Colonoscopy" (DVR number 0504211 from 17.10.2007 ).
Definitions
Advanced adenomas are defined as adenomas that are at least 10 mm in size or have high grade dysplasia, or villous or tubulovillous histology, or any combination thereof. Adenoma detection rate (ADR) is defined as the number of colonoscopies with at least one adenoma detected divided by the overall number of colonoscopies performed by respective endoscopists. This definition also applies correspondingly to advanced adenoma detection rate (AADR), polyp detection rate (PDR), and proximal lesion detection rate (PLDR). Proximal lesion is defined as a lesion located proximally to the sigmoid colon.
Quality of data entry, audit, and feedback Every year three randomly selected colonoscopy reports within the database are checked for data accuracy for each participating endoscopist in order to verify the accuracy of data entry. The endoscopist presents the original colonoscopy report, including all data assessed within the electronically submitted colonoscopy report and including the statement of the reporting pathologist as well as photographic documentation of the cecum. If one or more entries are incorrect (missing data or incorrect data), the participating endoscopist is asked to submit data on another five patients randomly selected from the database; if these data are also incorrect, the endoscopist is excluded from the quality assurance program. In exchange for data transmission, participants receive benchmark reports twice a year containing detailed information on their personal performance compared with the anonymized performance of other participating endoscopists, as well as with the performance of each Austrian federal state.
Hygiene control
As hygiene controls for colonoscopes are mandatory in hospitals, only hygiene inspections of colonoscopes used in private practices are required within the quality assurance project. A germfree sample of the working channel, and the air and water channels of the colonoscope, as well as of the rinsing fluid from the endoscope washing machine must be provided annually. Test results have been assessed electronically since 2010.
Statistical analysis
The detection rates were adjusted for age using the indirect method, and using the age distribution of all individuals who underwent colonoscopies between 2007 and 2014 as the reference population. Cecal intubation rates (CIR), and rates of sedation, complications, and excellent or good bowel preparation were similarly adjusted. The adjusted rates were then analyzed for time trends, and for differences between private practices and endoscopy units of hospitals or outpatient clinics, using linear mixed models, including fixed effects for period and setting, and random effects for period and endoscopist. Pearson correlation coefficients were computed between adjusted complication rates, adjusted proximal lesion detection rates, and adjusted ADRs for the period 2013/2014. The SAS System V9.4 (2014 SAS Institute Inc., Cary, North Carolina, USA) was used for statistical analysis, and the software package R (R Core Team, 2014, Vienna, Austria) was used for statistical graphics. 
Quality parameters and trends Detection rates
At least one polyp was found in 38.1 % of colonoscopies (n = 60 597), at least one adenoma was detected in 21.6 % (n = 34 365), and at least one advanced adenoma was detected in 6.3 % (n = 10 094). The polypectomy rate was 95.5 % (n = 57 890), and 97.3 % (n = 56 322) of the polyps were retrieved for pathological examination. Significant time trends were found for ADRs, which increased by + 1. ADR, adenoma detection rate; AADR, advanced adenoma detection rate; CIR, cecal intubation rate; PDR, polyp detection rate; PLDR, proximal lesion detection rate; N/A, not applicable. * Number of participants who provided data on bowel preparation for the respective year blocks: overall n = 0, n = 8, n = 150, n = 226; private practice n = 1, n = 8, n = 117, n = 174; hospital/outpatient clinics n = 0, n = 0, n = 33, n = 52.
centage points; 95 %CI 1.0 -6.9 percentage points; P = 0.01) compared with private practices. In private practices, the quality of bowel cleansing was excellent or good more often than in hospitals and outpatient clinics (+ 6.7 percentage points, 95 %CI 2.5 -10.9 percentage points; P < 0.01). CIRs were higher for hospitals and outpatient clinics (+ 1. 
Complications
Complications occurred in 0.2 % of all colonoscopies performed (n = 361). The most common complication was bleeding (n = 165, 0.1 % of all colonoscopies) followed by cardiopulmonary events (n = 134, 0.08 %) and others (n = 42, 0.03 %). Perforation occurred in 0.01 % of all colonoscopies (n = 20). In 341 cases with complications, patients reached a restitutio ad integrum (no consequential damage), one adverse event (a perforation) caused secondary damage, and 19 outcomes were unknown. There were no fatal outcomes reported in the screening cohort. Most (63.4 %, n = 229) of the complications occurred in colonoscopies in which polypectomy had been performed: 94.6 % (n = 156) of bleedings, 31.3 % (n = 42) of cardiopulmonary events, 55.0 % (n = 11) of perforations, and 47.6 % (n = 20) of other complications. About a third of complications (30.2 %, n = 109) occurred in colonoscopies with no pathological findings, 1.4 % (n = 5) in colonoscopies with at least one polyp detected but not resected, and 4.2 % (n = 15) in colonoscopies with pathological findings other than polyps. Sedation increased the probability of complications. Adverse events occurred in 0.24 % (95 %CI 0.21 % -0.26 %) of colonoscopies in which sedation was administered and in 0.16 % (95 %CI 0.11 % -0.22 %) of procedures without sedation (P = 0.03; relative risk 1.51, 95 %CI 1.05 -2.17). Notably, all perforations occurred in sedated patients; the perforation rate was 0.01 % in sedated patients (20/138 845; P = 0.17).
Data quality
Verification of the electronic documentation of data had been performed since 2011 (• " Table 3 To date, no endoscopist had to be excluded from the quality assurance project because of incorrect data entry. 
ADR, adenoma detection rate; CIR, cecal intubation rate.
Age-and-sex-adjusted adenoma detection rate (%) 
Hygiene control
In 2010, hygiene controls of endoscopic equipment used by 89 participants were required. In 7.9 % (n = 7) of cases, pathological germs were detected and the participants provided a second, germ-free result after eradication. In 2011, 98 private practices were certified, and 5.1 % (n = 5) had positive test result. This was a decrease of 2. 
Discussion
!
Screening colonoscopy in Austria performed within the quality assurance project described in this paper meets international standards in terms of both premalignant lesion detection rates and safety standards. Age-and sex-adjusted ADR significantly increased during the study period investigated from 22.2 % to 24.2 %, corresponding to an average increase of + 1.5 percentage points per 2-year period for an average endoscopist. In addition, the detection rate of proximal lesions increased from 15.8 % to 21.7 %. Overall, 95.5 % of polyps were resected, and 97.3 % of the retrieved polyps were sent for histopathological evaluation, which meets the requirement of 95 % [6] . Perforations occurred in 1:7962 colonoscopies and 1:7225 colonoscopies with polypectomy. Bleedings occurred in 1:521 colonoscopies with polypectomy. Possible reasons for higher complication rates in procedures with sedation are a reduced perception of pain by patients and subsequent failure of the endoscopist to notice alert signals.
Regarding data quality, the percentage of correct data entry increased by 13 percentage points in the first 3 years after implementation of the quality assurance project, and was 94 % in 2013. However, changes in the report form led to a deterioration in quality of data transmission. After the extension of the report form in 2013, which involved the inclusion of number of adenomas, resection technique (cold/high-frequency snare resection), and differentiation between screening and surveillance colonoscopy, the percentage of correct data entry decreased by 6 %. The percentages of contaminated endoscopes and washing machines were low. Overall, the rate of contaminated equipment decreased by 1.9 %. Interestingly, in 2013, a year when many private practices joined the quality assurance project, the proportion of contaminated instruments increased by 3.1 %; the following years, this rate was falling again. The awareness of endoscopic CRC prevention in Austria compared with the EU average is relatively high [18] . Past experiences have not only emphasized the importance of application of quality criteria, but also of monitoring via an independent structure in order to reveal deficiencies and provide options for intervention in an adequate and effective manner. In 2004, a report was published that revealed poor performance in screening colonoscopy in the United Kingdom, which was attributed to inadequate training [19] . The cecum was reached in less than 80 %, every fifth examination was performed with poor bowel preparation, only half of the patients recalled that they had been informed about possible adverse events before the procedure, and perforation occurred in 1:769 procedures [19] . As a consequence, public funding was provided to improve colonoscopy performance, not only by practical training, but also by the introduction of an Endoscopy Global Rating Score, a web-based self-assessment tool for use in endoscopy units [20] , and a National Bowel Cancer Screening Program, which implemented quality standards and an accreditation test for participation [21] . As a result, an improvement in quality was demonstrated in 2013 [22] ; for example, the adjusted CIR increased from 76.9 % to 95.8 % [19, 22] . In the [8] . Data from Austria confirmed that required ADR standards of ≥ 20 % [9] are met (currently 24.2 %) and stressed the need for sex-specific screening recommendations [11] . In US studies, a target ADR of > 15 % in women and > 25 % in men was proposed [5] . Recently, even higher ADR standards of ≥ 20 % for women and ≥ 30 % for men have been suggested [10, 23] . However, compared with most European studies, US guidelines are based on data from specialized centers and therefore applicability for outpatient clinics and office-based physicians is debatable. A German study group recently published a study on trends in screening colonoscopy. Brenner et al. reported an increase in ADR (nonadvanced adenoma detection rate increased from 13.3 % to 22.3 % in men and from 8.4 % to 14.9 % in women) in a study population of 4.4 million patients between 2003 and 2012. Age-adjusted CIR was > 98 % in 2003 and changed little during the study period investigated. Age-adjusted bleeding and perforation rates were 0.5 % and 0.1 %, respectively. The authors argued that the increase in ADRs results, at least partly, from an innovation effect [24] . The present study cohort also showed an increase in ADR (average + 1.5 percentage points per 2-years period overall, + 1.6 percentage points in men, and + 1.9 percentage points in women), as well as PDR (36.7 % to 42.0 %). Notably, also CIR increased significantly (from 94.2 % to 97.0 %). The positive effect of specific interventions on ADRs has been reported in several studies [25, 26] . Therefore, if studies on new benchmark requirement and/or new guidelines on screening are published, these publications are communicated to participating endoscopists by information letters. However, the positive trend in ADR in the present study might have resulted from many factors, such as: increasing awareness about the importance of ADR not related to the quality assurance program; possible changes in training and experience of participating endoscopists; possible changes in equipment and bowel preparation; differences in performance of incoming, leaving and continuing endoscopists; and trends in demographics and risk of screening participants. Constant audit and feedback in the form of benchmarking has certainly contributed to the strong increase in ADR in the present study population. In order to assess the amount of this increase that can be attributed to the quality assurance interventions, a comparison with endoscopies performed outside of the screening program is inevitable. However, like most other countries, in Austria there is no obligatory quality control program and therefore no universal assessment of ADR or other metrics. In order to make general statements on the trends in ADR and other quality parameters from a nationwide perspective, provision of colonoscopy reports and their assessment by an independent authority are mandatory, which underlines the strong need for respective guidelines comparable to the Germen model [24] . Another interesting finding was that although the ADR significantly increased over the investigated time period, the AADR decreased. AADR is known to be associated with sex and age [8, 11] . However, AADR in the present study cohort was presented separately for men and women (both decreased) and adjusted for age; age did not differentiate between the investigated time periods. Notably, there was wide variation in the detection of advanced adenomas as a proportion of all adenomas detected per endoscopists (median 25.6 %, interquartile range 16.7 % -38.3 %). Big differences in the percentage of individuals with advanced adenomas have been noted in other average-risk populations [27] . A possible explanation for the negative trend might lie in potential overdiagnosis of advanced adenomas in the earlier certification periods; overdiagnosis might have been due to the definition of advanced adenomas -a combination of a clinical (size, estimated by the endoscopist) and histopathological (amount of villous component, set by the pathologist) diagnosis -rather than higher prevalence rates. It has been shown that endoscopists tend to overestimate the size of a lesion [28] , which in combination with a villous histology of an adenoma leads to overdiagnosis of advanced adenomas. Moreover, to our knowledge there are no data on the accuracy of the diagnosis of a villous adenoma made by pathologists, which has major impact on the AADR. To date, approximately half of all endoscopy units in Austria participate voluntarily in the quality assurance project, which is an encouraging result. However, efforts to ensure more comprehensive coverage in the future are required, for example, by making participation in the quality assurance project a condition of participation in the national screening program, and providing appropriate financial reward for endoscopists. However, the implementation of the present quality assurance project was a milestone towards comprehensive assessment and objective demonstration of trends in adenoma, advanced adenoma, and polyp detection rates. The acquired database provides the unique opportunity to analyze trends in effectiveness of screening colonoscopy, which impacts on patient benefit and safety as well as cost-effectiveness. Therefore, publication of these data is expected to give an important impulse to negotiations in this matter. Limitations of this study include participation in the quality assurance project, which was on a voluntary basis; even though participation shows interest in and willingness to improve individual performance, it constitutes a possible bias by including particularly well trained endoscopists with above-average performance. A further limitation is the method of determining accuracy of the data captured in the database. Three randomly selected colonoscopy reports per endoscopist per year might be an insufficient number to monitor such a large data transfer. In the current form, the probability of missing incorrect data is rather high. However, the current personal and financial resources permit only this small sample test to be performed. Therefore, a future goal of the project is to acquire more resources in order to improve this very important issue. In addition, we did not assess colonoscope withdrawal time, which should be at least 6 minutes in screening colonoscopy [29] . However, inclusion of withdrawal time into the report form is a future goal of the project. Another limitation, which applies to most quality record forms, is the lack of assessment of patient comfort, despite this measure being recommended as an auditable outcome in screening colonoscopy in the EU guidelines [30] . In addition, complications are assessed solely in the electronic report form; there is no long-term followup (e. g. contacting patients after 30 days). Finally, although participants are obliged contractually to provide reports of all screening colonoscopies performed (provided the screened individuals have given written informed consent), and the count of screening colonoscopy is assessed twice a year in the benchmark reports, a certain selection bias cannot be excluded with absolute certainty.
